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Purpose. To analyze the association between hypothyroidism and keratoconus, we examined blood thyroid hormone levels and
corneal tomographic parameters in healthy subjects and patients with keratoconus. Methods. We included 626 subjects (304 left
eyes, 49%; 431 males, 69%; age 38.4± 14.3 y). Patients with keratoconus were from our Homburg Keratoconus Center (HKC)
(n� 463); patients with hypothyroidism were from the Department of Internal Medicine of Saarland Medical University,
Homburg/Saar, Germany (n� 75); and healthy subjects were from the Department of Ophthalmology of Saarland University
Medical Center (n� 88). We included only one randomly selected eye of each subject and the first examination data. Exclusion
criteria. Previous thyroid medication, previous ocular surgery, and patients with suspected keratoconus (topographic keratoconus
classification, [TKC]: 0< 1). Patient eyes were classified (TKC) with dedicated, instrument-based, keratoconus detection software
provided with the Pentacam. TKC� 0 was considered “normal,” and TKCs≥ 1 were considered keratoconus. Subjects were also
classified as euthyroid or hypothyroid, based on blood thyroid hormone status (i.e., TSH, FT3, and FT4). A multiple logistic linear
regression model was constructed to determine the effects of age (covariate), gender, and hypothyroidism (effect sizes) on “TKC-
positive” disease. Results. +e significance levels for a constant parameter, sex, thyroid condition, and age were p< 0.0001,
p< 0.0001, p< 0.0001, and p � 0.003, respectively. +e odds ratios for age, sex, and hypothyroidism were 0.98, 3.05, and 3.34,
respectively. Male sex and a euthyroid condition had significantly positive, clinically relevant effects, and age had a significantly
negative, but clinically irrelevant effect on the estimated TKC index. Conclusions. Keratoconus appeared to occur more often in
patients classified as euthyroid than in patients with hypothyroidism. +us, hypothyroidism alone could not support the de-
velopment of keratoconus. Based on these results, it should not be mandatory to screen patients with hypothyroidism for
keratoconus or patients with keratoconus for hypothyroidism.
1. Introduction
Keratoconus is a bilateral, “noninflammatory” condition of
the corneal tissue that causes progressive stromal thinning.
+is condition leads to a cone-shaped, central/paracentral,
ectatic cornea. Patients with keratoconus develop irregular
astigmatism and myopia [1]. Histopathologically, kerato-
conus corneas show central or paracentral stromal thinning,
ruptures in Bowman’s layer, and ring-shaped ferritin de-
positions at the basal layers of the corneal epithelium
(“Fleischer ring”) [2]. Patients with keratoconus can be
classified according to severity, based on Scheimpflug
technology: 0 (healthy), 1 (suspected), 2 (mild), 3 (moder-
ate), and 4 (severe). Keratoconus can also be classified with
keratometric values, as follows: mild (<48D), moderate
(48–54D), and severe (>54D) [3].
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+e prevalence of keratoconus is about 1 : 2000 in the
Caucasian population. It commonly appears during puberty,
progresses until the third or fourth decade of life, and then, it
typically stabilizes [1]. Numerous studies have suggested that
hormones, such as estrogen and testosterone, might have an
effect on the development of corneal ectasia [4–8].
Keratoconus is a multifactorial disease influenced by
environmental and genetic factors [1]. It is considered to be a
sporadic disease, but there is also evidence of autosomal
dominant [9] and autosomal recessive [10] inheritance.
Indeed, studies have shown associations between kerato-
conus and Down’s syndrome (0.5–15%) [11–13]; Turner’s
syndrome [14]; Leber´s congenital amaurosis [15]; con-
nective tissue disorders, such as Ehlers-Danlos [16] and
Marfan [17] syndromes; and mitral valve prolapse. In-
terleukin-1 may also play a role in the development of
keratoconus [18].
+e main environmental factor is a high-dose exposure
to ultraviolet light (UV). Due to the anterior location of the
cornea, about 80% of UVB light, which is entering the eye, is
absorbed through the corneal tissue. +is type of exposure
leads to the local production of reactive oxygen species
[2, 19]. In addition, the risk of keratoconus increases with
chronic keratocyte apoptosis or ongoing epithelial injury
(e.g., due to contact lens wear, chronic eye rubbing, or atopic
eye disease) [20, 21].
A thyroid gland dysfunction often results in thyroid-
associated ophthalmopathy [22]. +e diagnosis of a thyroid
gland disorder is based on changes in serum levels of free
thyroxine (FT4; normal range: 12–22 pmol/L), free tri-
iodothyronine (FT3; normal range: 3.1–6.8 pmol/L), and
thyroid-stimulating hormone (TSH; normal range: 0.27–
4.2mE/L). Hypothyroidism is a pathological condition,
where the cells of the human body do not receive the ap-
propriate FT4/FT3 effects. In primary hypothyreosis, FT4
and FT3 are reduced, and TSH is elevated in the blood.
Hypothyroidism might also be associated with keratoconus,
and it could be one of the causal factors [23–25].
+e purpose of the present study was to analyze the
association between hypothyroidism and keratoconus, by
examining blood thyroid hormone levels, corneal topo-
graphic/tomographic parameters, and biomechanical
parameters.
2. Patients and Methods
+is prospective single-center comparative study was con-
ducted at the Department of Ophthalmology, Saarland
University Medical Center in Homburg, Germany. +e
study was approved by the local ethics committee (Number
157/10) and followed the tenets of the Declaration of Hel-
sinki. Informed written consent was obtained from all
subjects.
2.1. Patient Selection. Patients with keratoconus were en-
rolled from our Homburg Keratoconus Center (HKC),
which was established in 2012 at the Department of Oph-
thalmology, Saarland Medical University, in Homburg/Saar,
Germany (n� 463). Patients with hypothyroidism were
enrolled from the Department of Internal Medicine of
Saarland Medical University, Homburg/Saar, Germany
(n� 75). Healthy subjects were enrolled from the De-
partment of Ophthalmology of Saarland University Medical
Center (n� 88). For this study, we acquired the examination
data for only one randomly selected eye of each subject.
We acquired data for patients examined between Jan-
uary 2012 and January 2016. We only used the first exam-
ination data; follow-up examination data were not used.
Exclusion criteria were a previous thyroid medication,
previous ocular surgery, and patients with suspected kera-
toconus (Pentacam topographic keratoconus classification
[TKC] 0< 1). We excluded patients with previous hypo-
thyroid medications to exclude a potential bias of hormone
supplementation. +erefore, we only included patients with
a new diagnosis of hypothyreosis (which had not yet used
medical treatment). Patients with previous ocular surgery
were excluded, because surgery could influence corneal
topography. Patients with suspected keratoconus were ex-
cluded, because a false diagnosis of keratoconus could also
result in a bias in the group of patients with keratoconus.
+is study included 4 patient groups: (1) subjects clas-
sified as euthyroid without keratoconus (controls), (2) pa-
tients classified as euthyroid with keratoconus, (3) patients
with hypothyroidism, but without keratoconus, and (4)
patients with hypothyroidism and keratoconus. Patient eyes
were classified as keratoconus with dedicated, instrument-
based, keratoconus detection software (topographic kera-
toconus classification, TKC) provided with the Pentacam
(see below). A TKC of 0 was considered normal, and TKC
values of 1 or higher were considered keratoconus. However,
as mentioned above, patients with suspected keratoconus
(TKC 0< 1) were excluded from the study.
Patients were considered euthyroid or hypothyroid,
based on blood thyroid hormone levels. Normal values were
defined as follows: 12–22 pmol/L for FT4, 3.1–6.8 pmol/L for
FT3, and 0.27–4.2mE/L for TSH. Patients with hormone
levels within these ranges were classified as euthyroid. Pa-
tients with lower FT4 and FT3 values or higher TSH values
were classified as patients with hypothyroidism [22].
2.2. Examination Protocol. All subjects received a complete
standard ophthalmological examination. In addition, sub-
jects were examined with a topographic modeling system for
corneal topography (TMS-5; Tomey, Nürnberg, Germany)
and with a rotating Scheimpflug camera (Pentacam HR,
Oculus Optikgeräte GmbH, Wetzlar, Germany). From the
anterior corneal surface data, we extracted the following
parameters: the surface asymmetry index (SAI), surface
regularity index (SRI), Klyce/Maeda keratoconus index
(KCI), Smolek/Klyce keratoconus severity index (KSI), and
keratoconus prediction index (KPI). From the tomographic
examination, the following parameters were extracted: the
index of surface variance (ISV), index of surface asymmetry
(IVA), keratoconus index (KI), center keratoconus index
(CKI), index of height asymmetry (IHA), and index of
height decentration (IHD). In addition, subjects were
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examined with the ocular response analyzer (ORA, Reichert
Ophthalmic Instruments, Buffalo, NY) to measure the
biomechanical properties of the cornea, including the fol-
lowing parameters: keratoconus match index (KMI), corneal
hysteresis (CH), and corneal resistance factor (CRF). We
used the noncontact EM-3000 specular microscope (Tomey,
Nürnberg, Germany) for evaluating the endothelial cell
density (ECD) and central corneal thickness.
+is study included 626 subjects (304 left eyes, 49%; 431
males, 69%; age 38.4± 14.3 y). Subjects were classified as
euthyroid (n� 458, 73%) or hypothyroid (n� 168, 27%),
based on blood thyroid hormone status (TSH, FT3, FT4). Of
the 458 subjects classified as euthyroid, 375 (80%) had
keratoconus and 83 (20%) did not have keratoconus. Of the
total study population of 626 subjects, 465 (74%) had ker-
atoconus, according to the TKC (Pentacam), and of these, 90
(19%) had hypothyroidism. Of the 161 patients without
keratoconus, 78 (48%) had hypothyroidism. Of the controls,
5 were diagnosed with a thyroid disorder, and none had
keratoconus.
2.3. Statistical Analysis. We performed statistical analyses
with SPSS 21.0 software. +e normality distribution was
checked for all parameters with the Kolmogorov–Smirnov
test.
+e TMS-5, Pentacam, ORA, and EM-3000 data were
analyzed descriptively, and results are expressed as the mean
and standard deviation or the median and interquartile
range for the 4 study groups. A nonparametric Mann–
Whitney U-test was used to evaluate differences in pa-
rameters between subjects classified as euthyroid, without or
with keratoconus (patient groups 1 and 2); between subjects
with hypothyroidism, without or with keratoconus (patient
groups 3 and 4); between subjects classified as euthyroid or
hypothyroid without keratoconus (patient groups 1 and 3);
and between subjects classified as euthyroid or hypothyroid
with keratoconus (patient groups 2 and 4).
A multiple logistic linear regression model was con-
structed to determine the effects of age (covariate), gender
(dichotomous factor), and hypothyroidism (dichotomous
factor: 1� hypothyroidism, 0� euthyroidism) on TKC-
positive disease (dichotomous factor: 0� no keratoconus
[TKC� 0], 1� keratoconus [TKC� 1–4]). +is model was
tested with a receiver-operating characteristics (ROC)
analysis, and the area under curve (AUC) was extracted as a
general descriptor. +e maximum Youden index value was
used as the threshold for separating keratoconus from
nonkeratoconus.
p values below 0.05 were considered statistically
significant.
3. Results
Figure 1 shows the disease distribution in different age
groups. Table 1 displays the serum FT4, FT3, and TSH levels
in different disease groups. Table 2 shows results from the
TMS-5 analysis of the anterior corneal surface. Table 3 shows
the results from Pentacam corneal tomography. Table 4
shows the corneal biomechanical properties from the
ORA evaluation. Table 5 shows the results from the corneal
endothelium evaluation with the EM-3000 specular endo-
thelial microscope.
We found significant differences between disease groups
in all corneal topographic, tomographic, and biomechanical
parameters. In addition, the central corneal thickness, mea-
sured with the EM-3000, was significantly different between
subjects classified as euthyroid, without or with keratoconus,
and between subjects with hypothyroidism, without or with
keratoconus (p< 0.05 for all; Tables 2–5). In addition, subjects
classified as euthyroid or hypothyroid without keratoconus
showed significant differences in the SRI, measured with the
TMS-5, the ISV, the IVA, and the IHD, measured with the
Pentacam, and the KMI,measured with theORA (p< 0.05 for
all; Tables 2–4). +e endothelial cell density was also signif-
icantly different between subjects classified as euthyroid,
without or with keratoconus (p< 0.05; Table 5).
In the generalized linear model, the absence/presence of
TKC (0� no keratoconus, 1� keratoconus) was modeled
with the following effect sizes: gender (1�male, 2� female)
and hypothyroidism (0� euthyroid, 1� hypothyroid). Ad-
ditionally, age (in years) was included as a covariate.
+e model equation yielded the TKC estimation, as
follows:
TKCest � 0.557 + 􏼪
0.218(if male)
0(if female) 􏼫
+ 􏼪
0.231(if euthyroid)
0(if hypothyroid) 􏼫 − 0.003 · age.
(1)
+e significance levels for the constant term, sex, thyroid
condition, and age were p< 0.0001, p< 0.0001, p< 0.0001,
and p � 0.003, respectively. +e odds ratios for age, sex, and
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Figure 1: +e disease distribution in different age groups.
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hypothyroidism were 0.98, 3.05, and 3.34, respectively.
Based on the linear model, male sex and the euthyroid
condition had clinically relevant, significantly positive effects
on the estimated TKC index. In addition, age had a tiny,
significantly negative, but clinically irrelevant, effect on the
estimated TKC index.
As proof-of-concept, we used this linear TKC estimation
equation to determine the best threshold for distinguishing
between keratoconus and normal corneas, with an ROC
analysis. +e ROC curve had an AUC of 0.74 (Figure 2). +e
maximum Youden index was 0.422, and the respective
threshold was 0.74. +e analysis yielded a sensitivity of 0.656
Table 1: Serum thyroid hormones: FT4 (pmol/L), FT3 (pmol/L), and TSH (mE/L) measured in different disease groups.
Disease group FT4 FT3 TSH
1. Euthyroid without keratoconus (n� 83) 1.20± 0.14 3.32± 0.42 1.50± 0.621.18; 0.22 3.30; 0.60 1.48; 0.83
2. Euthyroid with keratoconus (n� 375) 1.20± 0.13 3.45± 0.45 1.64± 0.571.19; 0.21 3.4; 0.50 1.63; 0.85
3. Hypothyroid without keratoconus (n� 69) 1.38± 0.27 3.11± 0.47 2.17± 1.741.36; 0.34 3.00; 0.70a 1.67; 2.43
4. Hypothyroid with keratoconus (n� 86) 1.29± 0.21 3.41± 0.46 2.72± 1.481.25; 0.24 3.40; 0.50 3.10; 2.20
Values represent the mean± standard deviation or the median; interquartile range, as indicated. aFor this group, n� 65.
Table 2: Anterior corneal surface parameters measured with the TMS-5 in different disease groups.
Disease group SAI SRI KCI KSI KPI
1. Euthyroid without keratoconus (n� 75) 0.55± 0.36 0.30± 0.36 2.29± 6.43 1.79± 5.76 0.21± 0.020.44; 0.37 0.19; 0.35a 0.00; 0.00 0.00; 0.00 0.21; 0.03
2. Euthyroid with keratoconus (n� 341) 2.57± 1.41 1.08± 0.62 64.08± 34.38 53.83± 25.97 0.36± 0.112.52; 1.86b 1.01; 0.93 76.80; 58.50 56.90; 39.90 0.36; 0.16b
3. Hypothyroid without keratoconus (n� 57) 0.47± 0.31 0.17± 0.23 4.76± 10.73 2.72± 8.26 0.21± 0.020.39; 0.33 0.07; 0.19 0.00; 0.00 0.00; 0.00 0.21; 0.03
4. Hypothyroid with keratoconus (n� 68) 2.55± 1.42 1.15± 0.62 60.62± 34.71 57.46± 27.21 0.35± 0.342.39; 1.97 1.06; 0.89 69.65; 60.80 61.35; 41.85 0.34; 0.17
Difference between groups
1-2 ∗∗ ∗∗ ∗∗ ∗∗ ∗∗
3-4 ∗∗ ∗∗ ∗∗ ∗∗ ∗∗
1–3 — ∗∗ — — —
2–4 — — — — —
Values represent the mean± standard deviation or the median; interquartile range, as indicated. aFor this group, n� 74; bfor this group, n� 340; ∗p< 0.05;
∗∗p< 0.01. SAI: surface asymmetry index; SRI: surface regularity index; KCI: Klyce/Maeda keratoconus index; KSI: Smolek/Klyce keratoconus severity index;
KPI: keratoconus prediction index.
Table 3: Corneal tomographic parameters measured with the Pentacam in different disease groups.
Disease group ISV IVA KI CKI IHA IHD
1. Euthyroid without keratoconus (n� 82) 21.31± 10.98 0.18± 0.15 1.02± 0.03 1.07± 0.67 6.42± 5.59 0.02± 0.1018.00; 14.00 0.15; 0.14 1.03; 0.04 1.00; 0.01 5.20; 6.60 0.01; 0.01
2. Euthyroid with keratoconus (n� 374) 101.17± 50.28 1.07± 0.52 1.26± 0.18 1.06± 0.24 34.65± 57.29 0.13± 0.1193.00; 59.00 1.00; 0.72 1.23; 0.19 1.04; 0.09 24.40; 33.42 0.11; 0.09
3. Hypothyroid without keratoconus (n� 78) 16.20± 6.25 0.12± 0.07 1.02± 0.02 1.00± 0.007 4.92± 4.46 0.01± 0.00915.00; 7.00 0.11; 0.08 1.02; 0.02 1.00; 0.01 3.40; 5.85 0.008; 0.008
4. Hypothyroid with keratoconus (n� 90) 102.64± 61.11 1.00± 0.49 1.25± 0.17 1.06± 0.08 30.87± 29.2 0.12± 0.0794.00; 66.75 0.98; 0.65 1.23; 0.22 1.05; 0.08 23.60; 29.17 0.11; 0.10
Difference between groups:
1-2 ∗∗ ∗∗ ∗∗ ∗∗ ∗∗ ∗∗
3-4 ∗∗ ∗∗ ∗∗ ∗∗ ∗∗ ∗∗
1–3 ∗∗ ∗∗ — — — ∗∗
2–4 — — — — — —
Values represent the mean± standard deviation or the median; interquartile range, as indicated. ∗p< 0.05; ∗∗p< 0.01. ISV: index of surface variance; IVA:
index of surface asymmetry; KI: keratoconus index; CKI: center keratoconus index; IHA: index of height asymmetry; IHD: index of height decentration.
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and a specificity of 0.766. +e mean absolute estimation
error was 0.210± 0.241.
4. Discussion
+emajor finding of our study was that patients classified as
euthyroid appeared to have keratoconus more often than
patients with hypothyroidism. As commonly described, KC
was more often present in males than in females. Moreover,
the risk of developing keratoconus decreased by 2% with
each year of age (odds ratio: 0.98).
Hormonal influences on the cornea have interested
researchers for a long time. During embryonic life, thyroid
hormone is essential for the development of corneal
transparency, and it is an important factor in initiating
corneal dehydration [26, 27]. +e presence of thyroxine
receptors was verified in chicken [28] and human corneas
[24]. Furthermore, a certain quantity of thyroxine is nec-
essary for the synthesis of corneal collagen [29].
During childhood, serum thyroxine (T4) levels decrease
in concert with a progressive reduction in thyroxine-binding
globulin (TBG). TBG levels are lowest in puberty, when
keratoconus typically appears or progresses [30]. +e thy-
roxine-binding capacity of TBG is also influenced by gender
hormones: estrogen increases and testosterone decreases
TBG binding capacity [31]. Interestingly, in spontaneous
mutant keratoconus mice, keratoconus was observed almost
exclusively in mature males, but not in castrated animals [4].
In spontaneous mutant keratoconus mice, systemic testos-
terone also led to keratoconus in females.
Estrogen receptors were also identified in human cor-
neas [8, 32]. One report hypothesized that keratoconus
might be triggered by estrogen [8], which might potentially
explain the keratectasia observed after refractive surgery
during pregnancy [5, 33]. +e pregnancy-induced pro-
gression of keratoconus was also studied by Bilgihan et al.
[34]. Fink et al. investigated the influence of gender and
hormone status on the severity and progression of
Table 4: Biomechanical parameters measured with the ocular response analyzer in different disease groups.
Disease group KMI CH CRF
1. Euthyroid without keratoconus (n� 78) 0.71± 0.39 10.00± 1.90 9.89± 1.950.67; 0.53 9.95; 2.62 9.55; 2.85
2. Euthyroid with keratoconus (n� 325) 0.09± 0.40 8.15± 1.73 7.06± 2.080.06; 0.57 8.10; 2.20 6.90; 2.50
3. Hypothyroid without keratoconus (n� 72) 0.81± 0.32 10.28± 1.88 10.00± 1.960.88; 0.42 9.95; 2.62 9.60; 2.80
4. Hypothyroid with keratoconus (n� 77) 0.04± 0.41 8.18± 2.05 7.00± 2.460.02; 0.57 8.30; 2.55 7.10; 2.70
Difference between groups:
1-2 ∗∗ ∗∗ ∗∗
3-4 ∗∗ ∗∗ ∗∗
1–3 ∗ — —
2–4 — — —
Values represent the mean± standard deviation or the median; interquartile range, as indicated. ∗p< 0.05; ∗∗p< 0.01. KMI: keratoconus match index; CH:
corneal hysteresis; CRF: corneal resistance factor.
Table 5: Corneal endothelium evaluated with the EM-3000 specular microscope in different disease groups.
Disease group Endothelial cell density Central corneal thickness
1. Euthyroid without keratoconus
2606± 360 507.69± 99.49
2690; 452 525.00; 60
(n� 70) (n� 65)
2. Euthyroid with keratoconus
2523± 362 451.44± 107.99
2558; 421 474.00; 73
(n� 302) (n� 277)
3. Hypothyroid without keratoconus
2586± 387 512.26± 98.75
2598; 401 528.00; 41
(n� 68) (n� 65)
4. Hypothyroid with keratoconus
2501± 382 459.36± 100.33
2558; 381 479.00; 83
(n� 62) (n� 58)
Difference between groups
1-2 ∗ ∗∗
3-4 — ∗∗
1–3 — —
2–4 — —
Values represent the mean± standard deviation or the median; interquartile range, as indicated. ∗p< 0.05; ∗∗p< 0.01.
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keratoconus. +ey could not verify any significant differ-
ences between midlife males, “hormone-active” females, and
“hormone-inactive” females [6].
Kahán et al. analyzed tear and blood samples of patients
with keratoconus. One-third of those patients had hypo-
thyroidism, half were classified as euthyroid, and all patients
with both hyperthyroidism and keratoconus were males
[35]. In comparison, in our study, we found that approxi-
mately 80% of patients classified as euthyroid and 20% of
patients with hypothyroidism had keratoconus, after ex-
cluding data from patients with hyperthyroidism. One
previous study claimed that keratoconus appeared after a
thyroidectomy [36]. Others found a reversible increase in
corneal thickness in patients with hypothyroidism, which
decreased with medical treatment [37].
+e association between hypothyroidism and kerato-
conus is rare. However, this association might be found
sporadically or in specific environmental or clinical con-
ditions, such as pregnancy or allergy [38]. +e relationship
between thyroid gland dysfunction and keratoconus pro-
gression was described as hypothyroxinemia in one patient
during pregnancy, by Gatzioufas and +anos [23]. +ey
found that Kmax and corneal thickness values of this patient
normalized after giving supplementary thyroxine medica-
tion [23]. Similar results were found in a study by Hoo-
gewound et al. [39]. In addition, Hafezi and Iseli found that
iatrogenic keratectasia progressed in pregnancy, despite the
administration of crosslinking therapy [40]. More recently,
+anos et al. described a crucial role of T4 in keratoconus
pathophysiology [25]. +ey found a 13.6% prevalence of
thyroid gland dysfunction among patients with keratoconus,
which was higher than the prevalence in the general pop-
ulation (∼2%) [25].
Our findings that patients classified as euthyroid
appeared to have keratoconus more often than patients with
hypothyroidism contradicted results found in previous
studies. However, with the exception of the study by +anos
et al., all other clinical studies mentioned above were case
reports, which did not include data for a large patient
population. In addition, no previous study analyzed the
effect of age or gender on disease characteristics, which we
analyzed in the present study. We excluded biases due to
different patient ages or genders with our multiple logistic
linear regression model.
It was not surprising to find significant differences in
all topographic, tomographic, and ORA parameters be-
tween patients classified as euthyroid with/without ker-
atoconus and between patients with hypothyroidism
with/without keratoconus [3]. For example, we found
significant differences in SRIs (TMS-5), ISVs, IVAs, and
IHDs (Pentacam) between patients classified as euthyroid
or hypothyroid, in the absence of keratoconus. In patients
with hypothyroidism, these findings could be due to dry
eye disease, which was not analyzed in the present study.
Dry eye disease is part of thyroid-induced ophthalm-
opathy [22]. Moreover, dry eye disease is known to cause
changes in topographic and tomographic parameters
[41].
We found an increase in the KMI, measured with ORA,
among patients with hypothyroidism compared to patients
classified as euthyroid, in the absence of keratoconus. +is
finding was partly consistent with the study by Gatzioufas
et al. [24].+ey showed that ORA parameters might increase
in patients with hypothyroidism, compared to normal
controls. +ey found increases in the CH and CRF, mea-
sured with ORA, among patients with hypothyroidism;
however, unlike our findings, they did not detect a difference
in KMI between groups.
5. Conclusion
Keratoconus appeared to occur more often in subjects clas-
sified as euthyroid compared to subjects with hypothyroid-
ism. +us, our findings showed that hypothyroidism alone
could not support the etiology of keratoconus. Nevertheless,
in rare cases, hypothyroidism has been reported in the
pathogenesis of keratoconus; thus, it represents a risk factor
during pregnancy and in rare conditions, particularly in
males, due to the high levels of testosterone and dehy-
droepiandrosterone sulphate. +erefore, hypothyroidism
could be considered an adjunctive progression factor, but not
an etiologic factor [4–8]. Although these data require further
analysis, the present results suggest that it should not be
mandatory to screen patients with hypothyroidism for ker-
atoconus or patients with keratoconus for hypothyroidism.
Data Availability
+e data used to support the findings of this study are in-
cluded within the article.
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Figure 2: Receiver-operating characteristics (ROC) curve for esti-
mating the TKC. A linear estimation equation was used to determine
the best threshold for distinguishing between keratoconus and
normal eyes with the ROC curve. +e area under the ROC curve is
0.74 (arrow). +e maximum Youden index is marked with an arrow
on the graph.+e Youden index is (sensitivity + specificity − 1) 0.422.
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